Gary W Falk Selected Research

Barrett Esophagus (Barrett's Esophagus)

1/2022	Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
1/2022	Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis.
1/2022	Guideline to Practice: Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
11/2019	Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development.
10/2017	Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice.
1/2017	A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
1/2017	Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
1/2017	Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
1/2017	Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
11/2016	Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary W Falk Research Topics

Disease

39	Barrett Esophagus (Barrett's Esophagus) 01/2022 - 05/2004
20	Neoplasms (Cancer) 10/2021 - 04/2003
17	Eosinophilic Esophagitis 11/2022 - 09/2008
10	Adenocarcinoma 10/2021 - 07/2009
8	Metaplasia 01/2022 - 06/2002
7	Inflammation (Inflammations) 01/2020 - 07/2011
7	Gastroesophageal Reflux (GERD) 12/2015 - 10/2006
7	Disease Progression 09/2014 - 08/2004
5	Deglutition Disorders (Dysphagia) 11/2022 - 09/2008
3	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 11/2016
3	Esophageal Achalasia (Megaesophagus) 10/2021 - 12/2016
3	Infections 08/2017 - 07/2009
2	Eosinophilic enteropathy 10/2020 - 01/2020
2	Asthma (Bronchial Asthma) 06/2020 - 11/2009
2	Esophagitis 01/2020 - 08/2017
2	Hyperplasia 01/2020 - 01/2017
2	Esophageal Diseases 03/2018 - 06/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2017 - 09/2014
2	Heartburn (Pyrosis) 01/2016 - 09/2008
2	Carcinoma (Carcinomatosis) 05/2015 - 06/2009
2	Carcinogenesis 04/2015 - 05/2012
2	Obesity 04/2015 - 05/2012
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2014 - 06/2003
2	Hypersensitivity (Allergy) 07/2011 - 01/2010
2	Chest Pain (Chest Pains) 05/2009 - 09/2008
1	Candidiasis (Moniliasis) 11/2022
1	Hiatal Hernia 01/2022
1	Esophageal Motility Disorders (Nutcracker Esophagus) 06/2021
1	Duodenitis 10/2020
1	Eosinophilia 01/2020
1	COVID-19 01/2020
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020
1	Necrosis 01/2017
1	Esophageal Perforation 12/2016
1	Pneumoperitoneum 12/2016
1	Mediastinal Emphysema (Pneumomediastinum) 12/2016
1	Food Hypersensitivity (Food Allergy) 04/2016

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2003
7	AcidsIBA 08/2017 - 06/2002
5	Proton Pump InhibitorsIBA 01/2022 - 09/2006
5	CytokinesIBA 01/2020 - 09/2011
4	acceleratory factor from growth hormone (AcG)IBA 01/2022 - 01/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2015 - 10/2008
3	SuspensionsIBA 01/2022 - 01/2020
3	AntigensIBA 04/2016 - 07/2011
2	SteroidsIBA 11/2022 - 01/2022
2	APT-1011IBA 11/2022 - 01/2020
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2022
2	AllergensIBA 01/2020 - 01/2010
2	AntioxidantsIBA 08/2017 - 09/2011
2	N 30IBA 01/2017 - 10/2012
2	ParaffinIBA 01/2017 - 07/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 07/2015
2	AdipokinesIBA 12/2015 - 09/2011
2	Insulin (Novolin)FDA Link 04/2015 - 05/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2015 - 07/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 02/2010
2	Esomeprazole (Nexium)FDA Link 10/2012 - 09/2006
2	NitrogenIBA 09/2011 - 10/2009
1	TabletsIBA 11/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 10/2021
1	AK002IBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2020
1	SolutionsIBA 06/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	AerosolsIBA 01/2020
1	dupilumabIBA 01/2020
1	Thromboxane A2 (A2, Thromboxane)IBA 11/2019
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	IceIBA 10/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	Interleukin-13IBA 01/2017
1	LeptinIBA 12/2015
1	AdiponectinIBA 12/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015

Therapy/Procedure

26	Therapeutics 01/2022 - 06/2002
10	Radiofrequency Ablation 09/2015 - 05/2009
3	Precision Medicine 01/2020 - 03/2018
2	Ambulatory Care (Outpatient Care) 01/2022 - 01/2022
2	Myotomy 06/2021 - 12/2016
2	Heller Myotomy 06/2021 - 12/2016
2	Esophagectomy 01/2020 - 06/2009
2	Ablation Techniques 01/2017 - 01/2017
2	Chemoprevention 11/2016 - 10/2008
2	Fundoplication 09/2011 - 06/2002
1	Surgical Instruments (Clip) 01/2022
1	Patient Transfer (Patient Dumping) 12/2021
1	Chemoradiotherapy 10/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Proton Therapy 10/2021
1	Salvage Therapy 06/2021
1	Nebulizers and Vaporizers (Inhaler) 06/2020
1	Cryotherapy (Therapy, Cold) 10/2017
1	Length of Stay 12/2016
1	Art Therapy 11/2016